为冠状病毒疫苗准备供应链

当我们争取冠状病毒大流行的“压平曲线”时，科学家们迫切地努力创造疫苗。在批准疫苗被批准时，制造和分配数亿剂量是解决问题的另一个挑战。

金镜头过度图高级内容战略家，对齐

5月1日，2020年

在大大减少的时间表中创建可行疫苗的问题是一项挑战 - 通常需要4年或更长时间的挑战。大流行期间的全球供应链已经在这么多方面受到了打击，因为分销渠道减缓，劳动力短缺和产品延迟使得进一步复杂化。计划分发疫苗需要额外的原材料和用品是一项任务，有人认为现在需要发生。

Vials, rubber stoppers, syringes and plungers will need to be available in quantities of hundreds of millions in the U.S. alone, and the distribution issues, confusion and shortages of necessary medical supplies currently being experienced to fight the virus should be a warning of much needed planning for the near future. According to a recent纽约时报文章，“细节仍然缺乏联邦机构将负责的缺乏”在白宫疫苗生产计划下的疫苗交付设备。

The article goes on to say that there are currently at least 69 countries that have banned or restricted the export of medical devices, medicines and protective equipment due to the coronavirus, and many U.S. manufacturers import glass tubing, polypropylene and rubber or silicone for their own operations, largely from China and India where lockdowns and export bans are also in place. To meet these needs, supply channels within the U.S. may have to come from manufacturers that are currently operating outside of the health care industry.

看所有道路都导致Covid-19的时间延迟

采购可能会令人生畏，但随着一位医生告诉了纽约时报，“好消息是我们有时间。”在疫苗正在开发中，必须缩放设备和包装生产。

看PMMI的冠状病毒点击响应资源这里。